It is now well accepted that tumor promotion in rodents by the okadaic acid class of compounds is linked to cancer progression in humans by the overexpression of PP2A inhibitors, via the same mechanism involving inhibition of PP2A activity (Fujiki et al. 2018a). The gene discussed is PTPA; the disease is cancer.